Literature DB >> 19005081

Relationship of genetic variability and depressive symptoms to adverse events after coronary artery bypass graft surgery.

Barbara Phillips-Bute1, Joseph P Mathew, James A Blumenthal, Richard W Morris, Mihai V Podgoreanu, Michael Smith, Mark Stafford-Smith, Hilary P Grocott, Debra A Schwinn, Mark F Newman.   

Abstract

OBJECTIVE: To assess genetic variability in two serotonin-related gene polymorphisms (MAOA-uVNTR and 5HTTLPR) and their relationships to depression and adverse cardiac events in a sample of patients undergoing coronary artery bypass surgery.
METHODS: A total of 427 coronary artery bypass graft (CABG) patients were genotyped for two polymorphisms and assessed for depressive symptoms at three time points, in accordance with the Center for Epidemiological Studies-Depression (CES-D): preoperative baseline; 6 months postoperative; and 1 year postoperative. Logistic regression was used to assess the association between depressive symptoms (CES-D = >16), genotype differences, and cardiac events. Because MAOA-uVNTR is sex-linked, males and females were analyzed separately for this polymorphism; sexes were combined for the 5HTTLPR analysis.
RESULTS: Depressed patients were more likely than nondepressed patients to have a new cardiac event within 2 years of surgery (p < .0001); depressed patients who carry the long (L) allele of the 5HTTLPR polymorphism were more likely than the short/short (S/S carriers to have an event (p = .0002). Genetic associations with 6-month and 1-year postoperative depressive symptoms do not survive adjustment for baseline depressive symptoms.
CONCLUSIONS: A serotonin-related gene polymorphism--5HTTLPR--was associated with adverse cardiac events post CABG, in combination with depressive symptoms. Because depressed patients with the L allele of the 5HTTLPR polymorphism were more likely to have an event compared with the S/S carriers, combining genetic and psychiatric profiling may prove useful in identifying patients at the highest risk for adverse outcomes post CABG.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19005081      PMCID: PMC2758292          DOI: 10.1097/PSY.0b013e318187aee6

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  32 in total

1.  Depression and cardiac mortality: results from a community-based longitudinal study.

Authors:  B W Penninx; A T Beekman; A Honig; D J Deeg; R A Schoevers; J T van Eijk; W van Tilburg
Journal:  Arch Gen Psychiatry       Date:  2001-03

2.  Serotonin-related gene polymorphisms and central nervous system serotonin function.

Authors:  Redford B Williams; Douglas A Marchuk; Kishore M Gadde; John C Barefoot; Katherine Grichnik; Michael J Helms; Cynthia M Kuhn; James G Lewis; Saul M Schanberg; Mark Stafford-Smith; Edward C Suarez; Greg L Clary; Ingrid K Svenson; Ilene C Siegler
Journal:  Neuropsychopharmacology       Date:  2002-08-29       Impact factor: 7.853

3.  Influence of serotonin-transporter-linked promoter region polymorphism on platelet activation in geriatric depression.

Authors:  E M Whyte; B G Pollock; W R Wagner; B H Mulsant; R E Ferrell; S Mazumdar; C F Reynolds
Journal:  Am J Psychiatry       Date:  2001-12       Impact factor: 18.112

4.  A human serotonin transporter mutation causes constitutive activation of transport activity.

Authors:  Fusun Kilic; Dennis L Murphy; Gary Rudnick
Journal:  Mol Pharmacol       Date:  2003-08       Impact factor: 4.436

5.  Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene.

Authors:  Avshalom Caspi; Karen Sugden; Terrie E Moffitt; Alan Taylor; Ian W Craig; HonaLee Harrington; Joseph McClay; Jonathan Mill; Judy Martin; Antony Braithwaite; Richie Poulton
Journal:  Science       Date:  2003-07-18       Impact factor: 47.728

6.  Depression as a risk factor for mortality after coronary artery bypass surgery.

Authors:  James A Blumenthal; Heather S Lett; Michael A Babyak; William White; Peter K Smith; Daniel B Mark; Robert Jones; Joseph P Mathew; Mark F Newman
Journal:  Lancet       Date:  2003-08-23       Impact factor: 79.321

Review 7.  Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment.

Authors:  Heather S Lett; James A Blumenthal; Michael A Babyak; Andrew Sherwood; Timothy Strauman; Clive Robins; Mark F Newman
Journal:  Psychosom Med       Date:  2004 May-Jun       Impact factor: 4.312

8.  Serotonin transporter gene polymorphism and myocardial infarction: Etude Cas-Témoins de l'Infarctus du Myocarde (ECTIM).

Authors:  Frédéric Fumeron; Dina Betoulle; Viviane Nicaud; Alun Evans; Frank Kee; Jean-Bernard Ruidavets; Dominique Arveiler; Gérald Luc; François Cambien
Journal:  Circulation       Date:  2002-06-25       Impact factor: 29.690

9.  Serotonin transporter promoter and intron 2 polymorphisms: relationship between allelic variants and gene expression.

Authors:  Dubravka Hranilovic; Jasminka Stefulj; Sibylle Schwab; Margitta Borrmann-Hassenbach; Margot Albus; Branimir Jernej; Dieter Wildenauer
Journal:  Biol Psychiatry       Date:  2004-06-01       Impact factor: 13.382

Review 10.  Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review.

Authors:  Lawson R Wulsin; Bonita M Singal
Journal:  Psychosom Med       Date:  2003 Mar-Apr       Impact factor: 4.312

View more
  13 in total

1.  The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation.

Authors:  Katja Karg; Margit Burmeister; Kerby Shedden; Srijan Sen
Journal:  Arch Gen Psychiatry       Date:  2011-01-03

2.  Depressive symptoms after CABG surgery: a meta-analysis.

Authors:  Simha Ravven; Caroline Bader; Armin Azar; James L Rudolph
Journal:  Harv Rev Psychiatry       Date:  2013 Mar-Apr       Impact factor: 3.732

Review 3.  Human serotonin transporter gene (SLC6A4) variants: their contributions to understanding pharmacogenomic and other functional G×G and G×E differences in health and disease.

Authors:  Dennis L Murphy; Pablo R Moya
Journal:  Curr Opin Pharmacol       Date:  2011-03-23       Impact factor: 5.547

4.  Population differences in associations of serotonin transporter promoter polymorphism (5HTTLPR) di- and triallelic genotypes with blood pressure and hypertension prevalence.

Authors:  Redford B Williams; George D Bishop; Brett C Haberstick; Andrew Smolen; Beverly H Brummett; Ilene C Siegler; Michael A Babyak; Xiaodong Zhang; E Shyong Tai; Jeannette Jen-Mai Lee; Maudrene Tan; Yik Ying Teo; Shiwei Cai; Edmund Chan; Carolyn Tucker Halpern; Eric A Whitsel; Shawn Bauldry; Kathleen Mullan Harris
Journal:  Am Heart J       Date:  2016-12-29       Impact factor: 4.749

5.  A prospective cohort study investigating factors associated with depression during medical internship.

Authors:  Srijan Sen; Henry R Kranzler; John H Krystal; Heather Speller; Grace Chan; Joel Gelernter; Constance Guille
Journal:  Arch Gen Psychiatry       Date:  2010-04-05

Review 6.  Gene-environment interactions in geriatric depression.

Authors:  Francis E Lotrich
Journal:  Psychiatr Clin North Am       Date:  2011-06

7.  Depression is associated with prolonged and complicated recovery following colorectal surgery.

Authors:  Courtney J Balentine; Jesus Hermosillo-Rodriguez; Celia N Robinson; David H Berger; Aanand D Naik
Journal:  J Gastrointest Surg       Date:  2011-07-23       Impact factor: 3.452

Review 8.  Psychological depression and cardiac surgery: a comprehensive review.

Authors:  Phillip J Tully
Journal:  J Extra Corpor Technol       Date:  2012-12

9.  Effects of Recent Stress and Variation in the Serotonin Transporter Polymorphism (5-HTTLPR) on Depressive Symptoms: A Repeated-Measures Study of Adults Age 50 and Older.

Authors:  Thalida E Arpawong; Jinkook Lee; Drystan F Phillips; Eileen M Crimmins; Morgan E Levine; Carol A Prescott
Journal:  Behav Genet       Date:  2015-09-02       Impact factor: 2.805

10.  Depression, anxiety, and cardiac morbidity outcomes after coronary artery bypass surgery: a contemporary and practical review.

Authors:  Phillip J Tully; Robert A Baker
Journal:  J Geriatr Cardiol       Date:  2012-06       Impact factor: 3.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.